Cargando…

Skin Adverse Reactions to Novel Messenger RNA Coronavirus Vaccination: A Case Series

Vaccines are actually the most effective strategy to control the COVID-19 spread and reduce mortality, but adverse reactions can occur. Skin involvement with novel messenger RNA coronavirus vaccines seems frequent but is not completely characterized. A real-world experience in the recent vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peigottu, Maria Francesca, Ferreli, Caterina, Atzori, Maria Giovanna, Atzori, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482130/ https://www.ncbi.nlm.nih.gov/pubmed/34562965 http://dx.doi.org/10.3390/diseases9030058

Ejemplares similares

Cutaneous drug eruptions associated with COVID-19 therapy
por: Atzori, Laura, et al.
Publicado: (2020)

Changing gears: Medical gloves in the era of coronavirus disease 2019 pandemic
por: Anedda, Jasmine, et al.
Publicado: (2020)

Clinicopathologic features between different viral epidemic outbreaks involving the skin
por: Atzori, Laura, et al.
Publicado: (2021)

Clinicopathologic features among different viral epidemic outbreaks involving the skin
por: Atzori, Laura, et al.
Publicado: (2022)

Don't forget about syphilis: sexually transmitted diseases during COVID-19 pandemic
por: Di Buduo, Andrea, et al.
Publicado: (2020)

COVID-19–related skin manifestations: Update on therapy
por: Atzori, Laura, et al.
Publicado: (2021)

Glomeruloid reactive angioendotheliomatosis in a woman with systemic lupus erythematosus and antiphospholipid syndrome mimicking reticular erythematous mucinosis
por: Ferreli, Caterina, et al.
Publicado: (2020)

Bullous pemphigoid triggered by COVID‐19 vaccine: Rapid resolution with corticosteroid therapy
por: Dell'Antonia, Massimo, et al.
Publicado: (2021)

Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine( )
por: Maron, Jenny S, et al.
Publicado: (2022)

Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination
por: Pizzatti, Laura, et al.
Publicado: (2020)

Multicentric reticulohistiocytosis revealing breast cancer: Report of a case with dermoscopic, radiological and therapeutic aspects
por: Dell’Antonia, Massimo, et al.
Publicado: (2021)

Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022)

Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
por: Collier, Ai-ris Y, et al.
Publicado: (2021)

Primary Localized Cutaneous Nodular Amyloidosis and Limited Cutaneous Systemic Sclerosis: Additional Cases with Dermatoscopic and Histopathological Correlation of Amyloid Deposition
por: Atzori, Laura, et al.
Publicado: (2021)

Clinicopathologic correlations of COVID-19–related cutaneous manifestations with special emphasis on histopathologic patterns
por: Rongioletti, Franco, et al.
Publicado: (2021)

Syphilis and the COVID-19 pandemic: Did the lockdown stop risky sexual behavior?
por: Bonato, Filippo, et al.
Publicado: (2021)

Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology
por: Piras, Viviana, et al.
Publicado: (2020)

Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Linear white lesion in the oral mucosa
por: Ferreli, Caterina, et al.
Publicado: (2019)

Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
por: Schauer, Jenna, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection
por: Gaebler, Christian, et al.
Publicado: (2022)

Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Adverse Reactions after BNT162b2 Messenger RNA Vaccination for Coronavirus Disease 2019 in Healthcare Workers Compared with Influenza Vaccination
por: Kim, A-Sol, et al.
Publicado: (2023)

Exercise improves long-term social and behavioral rhythms in older adults: Did it play a role during the COVID-19 lockdown?
por: Cossu, Giulia, et al.
Publicado: (2021)

Serologic Response to Messenger RNA Coronavirus Disease 2019 Vaccines in Inflammatory Bowel Disease Patients Receiving Biologic Therapies
por: Wong, Serre-Yu, et al.
Publicado: (2021)

Longitudinal Neutralizing and Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants Following Messenger RNA Coronavirus Disease 2019 Vaccination
por: Chen, Xuemin, et al.
Publicado: (2023)

Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era
por: Agha, Mounzer E, et al.
Publicado: (2021)

Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration
por: Vanijcharoenkarn, Kristine, et al.
Publicado: (2021)

Fatal hyalohyphomycosis with cutaneous involvement caused by Purpureocillium lilacinum in an immunocompromised patient with bullous pemphigoid
por: Corbeddu, Marialuisa, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 antibody response to a third dose of homologous messenger RNA vaccination in liver transplantation recipients
por: Strauss, Alexandra T., et al.
Publicado: (2022)

Non-surgical treatment of hidradenitis suppurativa: the role of cryotherapy
por: Dell'Antonia, Massimo, et al.
Publicado: (2023)

Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis
por: Pienkowski, Marek M., et al.
Publicado: (2022)

Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine
por: Drohan, Alex, et al.
Publicado: (2021)

Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
por: Ammitzbøll, Christian, et al.
Publicado: (2021)

Hyperinflammatory Syndromes After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA vaccination in Individuals With Underlying Immune Dysregulation
por: Rocco, Joseph M, et al.
Publicado: (2021)

Mediterranean diet, lifestyle and quality of life in Sardinian patients affected with Hidradenitis suppurativa
por: Velluzzi, Fernanda, et al.
Publicado: (2021)

Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease
por: Kappelman, Michael D., et al.
Publicado: (2021)

Outcomes of allergic-type reactions after messenger RNA coronavirus disease 2019 vaccination at 3 military medical centers
por: St. Clair, Benjamin D., et al.
Publicado: (2022)

Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose
por: Van Meerbeke, Sara W., et al.
Publicado: (2022)

Vaccine Communication: Appeals and Messengers Most Effective for COVID-19 Vaccine Uptake in Ukraine
por: Schulz, Gretchen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_15t6m1h12dk0h8aeet217c2pjq